
|Articles|December 3, 2019
PPD Expands Special Patient Capabilities
Advertisement
PPD, Inc. has expanded its early development research services by adding significant neuroscience and ethno-bridging expertise, broadening its capabilities to provide increased access to patients and special populations at PPD-owned clinical research units.
For more information, click
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
FDA Approves Oral Wegovy Following Positive Phase III OASIS 4 Trial Results
2
Controlled Clinical Trials in Sub-Saharan Africa: A Winning Value Proposition
3
ACT Brief: FDA Approval of Oral Wegovy, 2025’s Most-Read ACT Coverage, and Data Quality as the Foundation for AI
4
Our Top 5 Most Read Articles in 2025
5




